Embla Medical hf (OSSF.F) Stock Overview

Provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. More details

OSSF.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends0/6

OSSF.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Embla Medical hf. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Embla Medical hf
Historical stock prices
Current Share PriceDKK 4.15
52 Week HighDKK 5.18
52 Week LowDKK 4.08
Beta0.58
1 Month Change0%
3 Month Change1.72%
1 Year Changen/a
3 Year Change-9.19%
5 Year Change-39.86%
Change since IPO4.01%

Recent News & Updates

Recent updates

Shareholder Returns

OSSF.FUS Medical EquipmentUS Market
7D0%-0.6%0.6%
1Yn/a9.9%12.4%

Return vs Industry: Insufficient data to determine how OSSF.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how OSSF.F performed against the US Market.

Price Volatility

Is OSSF.F's price volatile compared to industry and market?
OSSF.F volatility
OSSF.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.6%
10% most volatile stocks in US Market17.1%
10% least volatile stocks in US Market3.3%

Stable Share Price: OSSF.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine OSSF.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19714,000Sveinn Solvasonwww.emblamedical.com

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.

Embla Medical hf. Fundamentals Summary

How do Embla Medical hf's earnings and revenue compare to its market cap?
OSSF.F fundamental statistics
Market capUS$2.17b
Earnings (TTM)US$72.18m
Revenue (TTM)US$857.82m
30.0x
P/E Ratio
2.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OSSF.F income statement (TTM)
RevenueUS$857.82m
Cost of RevenueUS$315.79m
Gross ProfitUS$542.03m
Other ExpensesUS$469.86m
EarningsUS$72.18m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Jul 22, 2025

Earnings per share (EPS)0.17
Gross Margin63.19%
Net Profit Margin8.41%
Debt/Equity Ratio46.9%

How did OSSF.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/18 05:21
End of Day Share Price 2025/03/21 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Embla Medical hf. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
null nullABG Sundal Collier Sponsored
Niels Granholm-LethCarnegie Investment Bank AB